Croda stock holds steady as 2025 results frame 2026

Croda International plc (ISIN GB00BJFFLV09) is framed today by its latest published 2025 figures, including revenue of GBP 1.63 billion, operating profit of GBP 245.0 million, and a reported operating margin of 15.0%. Those numbers remain the clearest anchor for Croda stock as investors assess the group's position into 2026.

Revenue and margin set the baseline

The 2025 revenue figure of GBP 1.63 billion gives a current scale reference, while operating profit of GBP 245.0 million shows how much of that turnover reached the bottom line before financing effects. The 15.0% operating margin is the key efficiency measure in the latest reported period.

Compared with the previous year, the operating margin gives the clearest quantified comparison in the available data set, because it shows how Croda converted sales into profit across 2025 rather than in a single quarter. For readers tracking the stock, that margin is more informative than headline revenue alone.

2026 investor focus

Croda's investor page remains the natural reference point for the company's 2026 updates, including any future trading commentary, capital allocation notes, or report dates. The latest accessible public context still points back to the 2025 base year rather than a fresh market-moving release.

That makes the current share story more dependent on how 2026 trading progress compares with the 2025 operating profit of GBP 245.0 million and the 15.0% margin already reported. If those levels hold or improve, the market case becomes easier to defend; if they soften, the comparison is immediate and visible.

What Croda sells

Croda's business remains centered on specialty ingredients used in consumer care, health care, and industrial applications. For stock readers, the relevance is that these end markets feed directly into revenue quality and margin stability, which are the two metrics already visible in the latest reported year.

Price and market view

Market-capitalization and live price data were not evidenced in the available search results for this call, so the article stays with the dated operating figures that are available and verified. The share narrative therefore rests on the 2025 revenue of GBP 1.63 billion, operating profit of GBP 245.0 million, and the 15.0% margin rather than on an unverified quote.

Croda stock is best read against those reported numbers until the next dated investor update adds a fresh market marker.

Read deeper on Croda

Use the investor page for the latest company updates and published financial context.

Specialty ingredients in focus

The representative product family here is Croda's specialty ingredients platform, which spans consumer care, health care, and industrial uses. That mix matters because the 2025 margin of 15.0% already suggests the portfolio can support profitability when demand conditions cooperate.

Closing view on the shares

Without a verified live price in the available results, the cleanest market reference remains the reported 2025 operating data. Croda stock is therefore best assessed against GBP 1.63 billion in revenue, GBP 245.0 million in operating profit, and a 15.0% margin as the newest hard numbers in view.